BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Castillo I, Bartolomé J, Quiroga JA, Barril G, Carreño V. Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 2011;31:1519-24. [PMID: 22093326 DOI: 10.1111/j.1478-3231.2011.02613.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Roque-Cuéllar MC, Sánchez B, García-Lozano JR, Praena-Fernández JM, Márquez-Galán JL, Núñez-Roldán A, Aguilar-Reina J. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells. Liver Int 2014;34:e80-8. [PMID: 24127783 DOI: 10.1111/liv.12320] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
2 Ali NK, Mohamed RR, Saleh BE, Alkady MM, Farag ES. Occult hepatitis C virus infection among haemodialysis patients. Arab J Gastroenterol. 2018;19:101-105. [PMID: 30245116 DOI: 10.1016/j.ajg.2018.09.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Farahani M, Bokharaei-Salim F, Ghane M, Basi A, Meysami P, Keyvani H. Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders. J Med Virol 2013;85:235-40. [PMID: 23168913 DOI: 10.1002/jmv.23460] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
4 Armandi A, Caviglia GP, Saracco GM, De Marco L, Fagoonee S, Pellicano R. Seronegative occult hepatitis C virus infection: what is its clinical relevance? Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02637-3] [Reference Citation Analysis]
5 Carreño V, Bartolomé J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol 2012; 18(23): 2887-2894 [PMID: 22736911 DOI: 10.3748/wjg.v18.i23.2887] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
6 Hedayati-Moghaddam MR, Soltanian H, Ahmadi-Ghezeldasht S. Occult hepatitis C virus infection in the Middle East and Eastern Mediterranean countries: A systematic review and meta-analysis. World J Hepatol 2021; 13(2): 242-260 [PMID: 33708353 DOI: 10.4254/wjh.v13.i2.242] [Reference Citation Analysis]
7 Cameron B, Galbraith S, Li H, Lloyd A; the HITS investigators. Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates. J Viral Hepat 2013;20:e96-e106. [DOI: 10.1111/jvh.12016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
8 Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, Ramezani-Binabaj M, Miri SM, Alavian SM. Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J. 2015;17:e34181. [PMID: 26734487 DOI: 10.5812/ircmj.34181] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pondé RA. Enzyme-linked immunosorbent/chemiluminescence assays, recombinant immunoblot assays and nucleic acid tests in the diagnosis of HCV infection. Eur J Clin Microbiol Infect Dis 2013;32:985-8. [PMID: 23666504 DOI: 10.1007/s10096-013-1857-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
10 Carreño V. Seronegative occult hepatitis C virus infection: clinical implications. J Clin Virol 2014;61:315-20. [PMID: 25304062 DOI: 10.1016/j.jcv.2014.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
11 Bartolomé J, Castillo I, Quiroga JA, Carreño V. Interleukin-28B polymorphisms and interferon gamma inducible protein-10 serum levels in seronegative occult hepatitis C virus infection. J Med Virol 2016;88:268-74. [PMID: 26147900 DOI: 10.1002/jmv.24322] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
12 Eslamifar A, Ramezani A, Ehteram H, Razeghi E, Ahmadi F, Amini M, Banifazl M, Etemadi G, Keyvani H, Bavand A, Aghakhani A. Occult hepatitis C virus infection in Iranian hemodialysis patients. J Nephropathol. 2015;4:116-120. [PMID: 26457258 DOI: 10.12860/jnp.2015.22] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Castillo I, Bartolomé J, Quiroga JA, Carreño V. High prevalence of occult hepatitis C virus infection in patients with chronic hepatitis B virus infection. J Med Microbiol 2013;62:1235-8. [PMID: 23639983 DOI: 10.1099/jmm.0.058297-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
14 Bartolomé J, Castillo I, Quiroga JA, Carreño V. Underestimation of occult hepatitis C virus infection in chronic haemodialysis and kidney transplant patients. J Hepatol 2014;61:1184-5. [PMID: 25135861 DOI: 10.1016/j.jhep.2014.06.040] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
15 Rezaee-Zavareh MS, Einollahi B. Treatment of occult hepatitis C virus infection: does it need special attention? Hepat Mon. 2014;14:e16665. [PMID: 25067939 DOI: 10.5812/hepatmon.16665] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
16 De Marco L, Manzini P, Trevisan M, Gillio-Tos A, Danielle F, Balloco C, Pizzi A, De Filippo E, D'Antico S, Violante B, Valfrè A, Curti F, Merletti F, Richiardi L. Prevalence and follow-up of occult HCV infection in an Italian population free of clinically detectable infectious liver disease. PLoS One 2012;7:e43541. [PMID: 22927986 DOI: 10.1371/journal.pone.0043541] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
17 Lybeck C, Brenndörfer ED, Sällberg M, Montgomery SM, Aleman S, Duberg AS. Long-term follow-up after cure from chronic hepatitis C virus infection shows occult hepatitis and a risk of hepatocellular carcinoma in noncirrhotic patients. Eur J Gastroenterol Hepatol 2019;31:506-13. [PMID: 30461522 DOI: 10.1097/MEG.0000000000001316] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
18 Papastergiou V, Stampori M, Lisgos P, Pselas C, Prodromidou K, Karatapanis S. Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C: a prospective study. Eur J Gastroenterol Hepatol. 2013;25:798-805. [PMID: 23395996 DOI: 10.1097/meg.0b013e32835eb8bf] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Attar BM, Van Thiel D. A New Twist to a Chronic HCV Infection: Occult Hepatitis C. Gastroenterol Res Pract. 2015;2015:579147. [PMID: 26221136 DOI: 10.1155/2015/579147] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
20 Wróblewska A, Bielawski KP, Sikorska K. Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus. JCM 2021;10:5874. [DOI: 10.3390/jcm10245874] [Reference Citation Analysis]
21 Khattab MA, Zakaria Y, Sadek E, Abd El Fatah AS, Fouad M, Khattab M, Moness HM, Adel NM, Ahmed E. Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response. Clin Exp Med. [DOI: 10.1007/s10238-022-00791-7] [Reference Citation Analysis]
22 Austria A, Wu GY. Occult Hepatitis C Virus Infection: A Review. J Clin Transl Hepatol. 2018;6:155-160. [PMID: 29951360 DOI: 10.14218/jcth.2017.00053] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]